Injectable Targets Décolleté Wrinkles - Summary - MDSpire
FDA & Government News

Injectable Targets Décolleté Wrinkles

New indication expands use of injectable biostimulator beyond the face.

Share

The FDA has approved RADIESSE, a dermal filler, for treating wrinkles in the décolleté area for individuals aged 22 and older. This injectable stimulates collagen and elastin production, offering lasting results up to two years. Clinical trials show over 80% patient satisfaction with skin tightness post-treatment, and 90% of providers noted visible improvements within four months. However, potential adverse effects include bruising and serious complications from improper injection. Usage is contraindicated for those with certain allergies and specific health conditions.

Original Source(s)

Injectable Targets Décolleté Wrinkles

  • by Kathryn Wighton

  • April 10, 2026

Related Content

Cupping vs UVB: Comparable Psoriasis Outcomes?

Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.

Forensic Dermatology and the CSI Effect

Media portrayals of forensic skin evidence create unrealistic jury expectations—and dermatologists testifying in court may need strategies to address them

AAD Issues Pediatric Atopic Dermatitis Guidelines

Two companion guidelines provide 41 evidence-based recommendations on treatment and prevention, along with 29 statements on comorbidity associations in patients under 18